Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Lunai Bioworks Inc. Director's Dealing 2023

Oct 24, 2023

34813_dirs_2023-10-24_9989ea4a-e4ef-47ee-aa46-b29ad4daa46c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: RENOVARO BIOSCIENCES INC. (RENB)
CIK: 0001527728
Period of Report: 2023-10-04

Reporting Person: Boeren Leni (Director)

More from Lunai Bioworks Inc.

Regulatory Filings 2026
May 20
Interim / Quarterly Report 2026
May 15
Regulatory Filings 2026
May 13
Regulatory Filings 2026
May 11
Regulatory Filings 2026
May 1
Regulatory Filings 2026
Apr 28
Proxy Solicitation & Information Statement 2026
Apr 13
Regulatory Filings 2026
Feb 23
Interim / Quarterly Report 2026
Feb 17
Regulatory Filings 2026
Feb 12
View all filings →